It might sound like science fiction, or a recent episode of "Silicon Valley," but a start-up called Ambrosia is charging $8,000 for blood transfusions from young people.
About 100 people have signed up to receive an infusion, founder Dr. Jesse Karmazin said Wednesday at the Code Conference.
Anyone over age 35 can become an Ambrosia customer, said Karmazin, but most of the early adopters tend to be of retirement age. He also stressed that it's a range of people, and not just Bay Area technologists, who have signed up.
The donated blood typically comes from teenagers, although anyone under age 25 is eligible. The company buys its supply from blood banks, which also sell blood to pharmaceutical companies. So high-schoolers donating their blood are not aware that it might be used on healthy adults.
Speaking to a roomful of technologists, Karmazin explained that the company does not claim that it can cure aging. Instead, he's hoping to recruit hundreds more people to research whether the transfusions can help fight particular symptoms associated with aging. Traditionally, biological aging hasn't been treated as a disease, which makes it challenging to study.
More:
http://www.cnbc.com/2017/05/31/blood-transfusions-from-teenagers-start-up-charging-8000-apiece.htmlWhy not call it Bathory's and be done with it?
